Market revenue in 2023 | USD 41.2 million |
Market revenue in 2030 | USD 71.8 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 64.81% in 2023. Horizon Databook has segmented the UAE veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary API manufacturing market in UAE is anticipated to showcase substantial growth over the forecast period. The increasing number of pets and the growing adoption of animal healthcare infrastructure are likely to spur market growth. In addition, the growing demand for livestock products is expected to drive market growth.
Moreover, the UAE government has been heavily investing in the development of advanced healthcare infrastructure, and veterinary research is anticipated to create growth opportunities for veterinary API manufacturers in the country.
Furthermore, the growing inclination toward pet insurance policies and increasing awareness regarding animal health & zoonotic diseases are driving the veterinary API manufacturing market in the UAE.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UAE veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account